Is SCHF a Good Investment? The Case For and Against (2026)
Last updated November 2026
Short answer
The case for SCHF is simple: low-cost, diversified exposure to FTSE Developed ex US Index at a 0.03% expense ratio, anchored by names like 005930.KS, 000660.KS, ASML. If that is the exposure you want and you do not already own most of it through another fund, SCHF is a strong core holding. The trade-offs are concentration in its top names and overlap with broad-market funds you may already hold. Whether it is a buy comes down to whether you want FTSE Developed ex US Index and at what cost. Not a recommendation; Walnut is not an investment adviser.
What are you buying with SCHF?
SCHF tracks a FTSE developed-markets-ex-US index, holding roughly 1,500 large- and mid-cap stocks across Europe, Japan, Canada, and Australia at a 0.03% expense ratio. It deliberately excludes both the US and emerging markets. The key nuance versus Vanguard's VEA and iShares's IEFA is minimal: all three are near-identical low-cost developed-international funds, so the choice tends to come down to which platform and cost structure you prefer.
Largest holdings (approximate as of November 2026; verify on Schwab Asset Management's fund page):
| Rank | Ticker | Company | % of SCHF | |
|---|---|---|---|---|
| 1 | 005930.KS | Samsung Electronics | 2.7% | |
| 2 | 000660.KS | SK hynix | 2.1% | |
| 3 | ASML | ASML Holding | 2.1% | |
| 4 | SHEL.L | Shell | 1.09% | |
| 5 | NOVN.SW | Novartis | 1.05% | |
| 6 | HSBA.L | HSBC Holdings | 1.01% | |
| 7 | RY.TO | Royal Bank of Canada | 0.98% | |
| 8 | AZN.L | AstraZeneca | 0.97% | |
| 9 | NESN.SW | Nestle | 0.92% |
What's the case for SCHF?
SCHF is the Schwab International Equity ETF, holding roughly 1,500 large- and mid-cap stocks in developed markets outside the US at a 0.03% expense ratio, one of the lowest in the category. It tracks a developed-markets index, so it covers Europe, Japan, Canada, and Australia but excludes emerging markets. Top holdings as of November 2026 include Samsung Electronics, SK hynix, ASML, Shell, and Novartis. Its closest peers are Vanguard's VEA and iShares's IEFA, which do nearly the same job at similarly tiny fees. SCHF's distinguishing trait is simply that ultra-low cost paired with Schwab's commission-free platform.
In its favour: it gives you FTSE Developed ex US Index exposure in one ticker at a 0.03% expense ratio, which is simple to hold and cheap to own.
What should you weigh before buying SCHF?
- Cost vs alternatives: 0.03% is the fee; compare it to funds tracking a similar index.
- Concentration: check how much of SCHF sits in its largest holdings (005930.KS, 000660.KS, ASML).
- Overlap: if you already own a broad-market fund, you may already hold much of this.
- Tracking scope: SCHF only gives you FTSE Developed ex US Index; it will not capture what sits outside that index.
How concentrated is SCHF?
“Diversified” is the word every index fund uses and it hides a wide range. The number that actually matters is how much of the fund sits in its largest positions, because that is the part that drives the return. In SCHF, the three largest positions are about 6.9% of the fund and the 9 largest are about 12.9%, with the single biggest at roughly 2.7%. Those are approximate weights as of November 2026, and because this is only the published top 9, treat 12.9% as a floor on concentration. The full book could be more concentrated. Verify with Schwab Asset Management.
SCHF is a well spread fund. No small group of names drives it, so the return will track its index closely.
The same number decides whether SCHF adds diversification to your portfolio in particular. A fund can be well spread on its own and still concentrate you further, if its largest holdings are names you already own directly or through another fund. Answering that means looking at your account as well as at SCHF, and it is the question to settle before you buy.
What SCHF does not give you
A fund is defined as much by what it leaves out as by what it holds, and the exclusions are rarely on the marketing page. SCHF tracks FTSE Developed ex US Index, so anything outside that index is simply absent from your portfolio no matter how much of the fund you own.
In practice that means checking three gaps. Whether the geography you want is covered, since a US index holds no international companies and a developed-markets index holds no emerging ones. Whether the size band you want is covered, because a large-cap index excludes the smaller companies some investors specifically want exposure to. And whether the asset class you want is covered at all, since an equity fund holds no bonds and gives you nothing to rebalance against in a drawdown.
None of these are faults; the fund is doing what it says. The mistake is assuming that owning a diversified fund means being diversified, when it means being diversified within one index.
When SCHF is the wrong choice
Some specific cases where it does not fit:
- You already own most of it. If a broad-market fund you hold already contains 005930.KS, 000660.KS, ASML at meaningful weight, adding SCHF mostly increases your exposure to the same companies while adding a second fee. Overlap like this is the single most common way people accidentally concentrate.
- You want the exposure for a short horizon. An index fund is a way to own an asset class over years. Over months it is simply the index, with all of the index's volatility and none of the compounding that makes holding it worthwhile.
- You need income you can rely on. Distributions from an equity index fund vary with what the underlying companies pay, so they are not a schedule you can plan around the way a bond ladder is.
- A cheaper fund tracks the same thing. Where two funds follow a similar index, the difference in expense ratio is one of the few advantages available to you without taking extra risk. Compare before assuming 0.03% is competitive.
How do you decide if SCHF is a buy?
The useful question is rarely “will SCHF go up?” It is “does this exposure fit my plan, at a cost I am happy with, without doubling up on what I already own?” Walnut connects your real brokerage so you can see exactly how SCHF would overlap with your current holdings, analyze it by chatting through Claude or ChatGPT, and place any trade yourself. You stay in control.
The bottom line on SCHF
The bottom line: SCHF is a low-cost core building block for FTSE Developed ex US Index exposure, not a tactical bet on a single name. If you want FTSE Developed ex US Index exposure and the 0.03% fee is competitive for you, it does its job well. If you already own that exposure through another fund, adding it mostly doubles a fee without adding diversification. Decide from your goal and your existing holdings, not from where the market sat last week. Walnut is not an investment adviser.
More on SCHF
- What is SCHF? (holdings, cost, performance, and the themes it covers)
- SCHF dividend: yield and schedule
- SCHF forecast: what analysts expect for its holdings
Your questions about SCHF
Ask Walnut's AI anything about SCHF and see how it fits what you own.
FAQ
Is SCHF a good ETF to buy?
+
Walnut is informational, not investment advice. Whether SCHF fits depends on your goals, time horizon, and what you already hold. It tracks FTSE Developed ex US Index at a 0.03% expense ratio, so the questions that matter are whether you want that exposure, whether you already own it through another fund, and whether the cost is competitive for what it does.
What does SCHF actually hold?
+
SCHF tracks FTSE Developed ex US Index. Its largest positions include 005930.KS, 000660.KS, ASML, SHEL.L, NOVN.SW and others (approximate, verify on Schwab Asset Management's fund page). The holdings are what you are really buying, not the ticker.
What is SCHF's expense ratio?
+
0.03% as of November 2026. Over decades, the expense ratio is one of the few things you can control, so compare it against close alternatives that track a similar index.
Does SCHF pay a dividend?
+
SCHF distributes a dividend with an approximate yield of 3.11% (November 2026). See the SCHF dividend page for how distributions work. Verify the current figure with Schwab Asset Management.
What are the risks of buying SCHF?
+
Like any index ETF, weigh concentration (how much sits in the top holdings), overlap with funds you already own, and whether FTSE Developed ex US Index matches the exposure you actually want. SCHF only gives you FTSE Developed ex US Index, not what sits outside it.
How do I decide if SCHF is right for me?
+
Start from your goal, then check four things: what SCHF holds, its cost versus alternatives, how much it overlaps with what you already own, and whether the exposure fits your time horizon and risk tolerance. Walnut can analyze the overlap against your real holdings; you keep your broker and approve any trade.
Walnut is informational, not investment advice. Figures are approximations stamped to November 2026; verify current data with Schwab Asset Management or your broker. Nothing here is a recommendation to buy, sell, or hold any security.